Therefore, we investigated the abnormal expression of CD56 and CD38 in CML neutrophils to explore their diagnostic value in identifying CML through flow cytometry. This evidence concerns the gene NCAM1 and chronic myelogenous leukemia, BCR-ABL1 positive.